跳到正文
PR Newswire Health·· 3 小时前AI 评分18

Mabtech 全系抗体与免疫检测产品纳入 Fisher Scientific 的 Encompass 优选采购计划

Mabtech Joins Fisher Scientific's Encompass Preferred Procurement Program

AI 导读

Mabtech 宣布其全部产品组合已可通过 Fisher Scientific 的 Encompass 优选采购计划订购,美国研究人员能在实验室既有的采购系统中直接采购。

正文 · 原文

US researchers can now order the full Mabtech portfolio of antibodies, immunoassay kits and readers through a purchasing channel their labs already use

, /PRNewswire/ -- Mabtech AB, a Swedish developer of immunoassays and instruments for life science research, today announced that its complete product portfolio is now available through Fisher Scientific's Encompass Preferred procurement program. Researchers in the United States can now source Mabtech products directly through the purchasing systems their institutions already rely on.

Mabtech's ELISpot kits, now available, along with all other Mabtech products, through FisherScientific Encompass Preferred.

Mabtech's ELISpot kits, now available, along with all other Mabtech products, through FisherScientific Encompass Preferred.

The agreement covers the entire Mabtech range. This includes monoclonal antibodies, ELISpot and FluoroSpot kits for single-cell secretion analysis, ELISA kits for plasma and serum analysis, and EYRAplex bead-based multiplex kits for cytokine and protein quantification. Mabtech instruments are also included: the IRIS 2 and ASTOR 2 ELISpot and FluoroSpot readers, powered by patented RAWspot technology, and EYRA, a fluidics-free magnetic bead-based multiplex instrument.

Encompass is Fisher Scientific's third-party vendor aggregation, procurement and supply chain program. It gives customers access to more than 1.5 million products that are typically unavailable through laboratory distribution channels. For labs that already order through Fisher Scientific, adding Mabtech products to an order now follows the same familiar workflow.

The new channel serves vaccine developers, immunologists and translational research teams who measure immune responses with high sensitivity. Existing Mabtech customers keep working with the exact antibodies and assay performance their protocols are built on. Labs new to Mabtech gain a simple route to adding ELISpot, FluoroSpot or multiplex assays to their research.

"The United States is home to one of the most active immunology research communities in the world, and we want our tools to be as easy to reach as possible for those scientists," said Phill Keefe, CEO of Mabtech. "Joining Encompass Preferred is an important step in our long-term commitment to the US market. It lets researchers put their time and energy into the science while purchasing runs through systems they already trust."

"Procurement processes vary a lot between institutions, and adding a new supplier can take weeks," said Todd Bennett, Chief Commercial Officer at Mabtech. "With our full portfolio on Encompass, a lab can add an ELISpot kit or an IRIS reader to its next Fisher Scientific order. Our customers still have direct access to Mabtech's sales people, application scientists and support team, so they get the same expertise they count on today."

How to order

US customers can find Mabtech products at fishersci.com/encompass or by contacting their Fisher Scientific sales representative. Fisher Scientific customer service is available at 1-800-766-7000. For product and application questions, researchers can reach Mabtech directly at mabtech.com.

About Mabtech

Founded in 1986 and headquartered in Nacka Strand, Sweden, Mabtech develops immunoassays and instruments for life science research. The company supplies high-quality monoclonal antibodies along with ELISpot, FluoroSpot, ELISA and EYRAplex bead-based multiplex kits. Its IRIS 2, ASTOR 2 and EYRA instruments support researchers worldwide in measuring immune responses, from single-cell cytokine secretion to multiplex analysis in solution. Mabtech is privately owned and serves customers globally through direct sales and a network of distributors.

Media contact

Jens Gertow, Chief Marketing Officer
Mabtech AB
[email protected]

SOURCE Mabtech

来源:PR Newswire Health · prnewswire.com

AI 摘要声明:站内标题、摘要与推荐理由由模型基于公开来源生成,属机器生成内容,非原文;本页内容仅供医药行业信息参考,不构成医疗建议、诊断或用药依据。